The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Reporting owner

LEIDEN JEFFREY M

Reporting owner CIK 0001242825 · Executive Chairman · Director

View SEC filings ↗

These transactions appear in filings associated with this reporting owner. Jointly reported quantities and amounts are unallocated; they are not this owner's individual purchases or total holdings. Names and roles reflect the relevant filing, and a reporting owner may be a person or an organization.

Reset

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.LEIDEN JEFFREY MLEIDEN JEFFREY MLEIDEN JEFFREY M · December 4, 2025 · Exercise / conversion · Common StockLEIDEN JEFFREY M · December 3, 2025 · Exercise / conversion · Common StockLEIDEN JEFFREY M · November 14, 2025 · Exercise / conversion · Common StockLEIDEN JEFFREY M · November 14, 2025 · Exercise / conversion · Common StockLEIDEN JEFFREY M · November 13, 2025 · Exercise / conversion · Common StockNov 13, 2025Dec 4, 2025
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

5 dated transactions · 1 of 1 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Dec 4, 2025VERTEX PHARMACEUTICALS INC / MACommon StockLEIDEN JEFFREY MExercise / conversion
Dec 3, 2025VERTEX PHARMACEUTICALS INC / MACommon StockLEIDEN JEFFREY MExercise / conversion
Nov 14, 2025VERTEX PHARMACEUTICALS INC / MACommon StockLEIDEN JEFFREY MExercise / conversion
Nov 14, 2025VERTEX PHARMACEUTICALS INC / MACommon StockLEIDEN JEFFREY MExercise / conversion
Nov 13, 2025VERTEX PHARMACEUTICALS INC / MACommon StockLEIDEN JEFFREY MExercise / conversion

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Transactions in associated filings

Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedCompanyReporting ownersType / securityQuantityPrice / reference valueDetails
Trade: VERTEX PHARMACEUTICALS INC / MAVRTX · company listings
LEIDEN JEFFREY MExecutive Chairman · Director
Exercise / conversionCommon StockNon-derivative security · Code M191.05Value: 91.05Currency not specifiedView ↗
Trade: VERTEX PHARMACEUTICALS INC / MAVRTX · company listings
LEIDEN JEFFREY MExecutive Chairman · Director
Exercise / conversionCommon StockNon-derivative security · Code M63,78186.52Value: 5,518,332.12Currency not specifiedView ↗
Trade: VERTEX PHARMACEUTICALS INC / MAVRTX · company listings
LEIDEN JEFFREY MExecutive Chairman · Director
Exercise / conversionCommon StockNon-derivative security · Code M39,76986.52Value: 3,440,813.88Currency not specifiedView ↗
Trade: VERTEX PHARMACEUTICALS INC / MAVRTX · company listings
LEIDEN JEFFREY MExecutive Chairman · Director
Exercise / conversionCommon StockNon-derivative security · Code M13,83591.05Value: 1,259,676.75Currency not specifiedView ↗
Trade: VERTEX PHARMACEUTICALS INC / MAVRTX · company listings
LEIDEN JEFFREY MExecutive Chairman · Director
Exercise / conversionCommon StockNon-derivative security · Code M19,68891.05Value: 1,792,592.4Currency not specifiedView ↗